Avantor, Inc. Repayments of Long-Term Debt
Avantor, Inc. (AVTR) reported Repayments of Long-Term Debt of $105.40 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-04-29.
Financial Statements › Cash Flow › Financing Activities
us-gaap:RepaymentsOfLongTermDebt · last filed 2026-04-29
- Avantor, Inc. repayments of long-term debt for the quarter ending 2026-03-31 was $105.40M, a 236.74% increase year-over-year.
- Avantor, Inc. repayments of long-term debt for the quarter ending 2025-12-31 was $949.00M, a 25.40% increase year-over-year.
- Avantor, Inc. repayments of long-term debt for the quarter ending 2025-09-30 was $439.20M, a 117.43% increase year-over-year.
- Avantor, Inc. repayments of long-term debt for the quarter ending 2025-06-30 was $6.80M, a 96.06% decline year-over-year.
- Avantor, Inc. repayments of long-term debt for fiscal 2025 was $1.43B, a 6.30% increase from fiscal 2024.
- Avantor, Inc. repayments of long-term debt for fiscal 2024 was $1.34B, a 58.61% increase from fiscal 2023.
- Avantor, Inc. repayments of long-term debt for fiscal 2023 was $846.00M, a 10.67% decline from fiscal 2022.
- Avantor, Inc. repayments of long-term debt for fiscal 2022 was $947.00M, a 77.37% increase from fiscal 2021.
| Period end | Repayments of Long-term Debt 3 month | Repayments of Long-term Debt 6 month | Repayments of Long-term Debt 9 month | Repayments of Long-term Debt 12 month |
|---|---|---|---|---|
| 2026-03-31 | $105.40M 10-Q · filed 2026-04-29 | $1.05B derived: sum of 2 quarters · filed 2026-04-29 | $1.49B derived: sum of 3 quarters · filed 2026-04-29 | $1.50B derived: sum of 4 quarters · filed 2026-04-29 |
| 2025-12-31 | $949.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $1.39B derived: sum of 2 quarters · filed 2026-02-11 | $1.40B derived: sum of 3 quarters · filed 2026-02-11 | $1.43B 10-K · filed 2026-02-11 |
| 2025-09-30 | $439.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $446.00M derived: sum of 2 quarters · filed 2025-10-29 | $477.30M 10-Q · filed 2025-10-29 | $1.23B derived: sum of 4 quarters · filed 2026-04-29 |
| 2025-06-30 | $6.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-01 | $38.10M 10-Q · filed 2025-08-01 | $794.90M derived: sum of 3 quarters · filed 2026-04-29 | $996.90M derived: sum of 4 quarters · filed 2026-04-29 |
| 2025-03-31 | $31.30M 10-Q · filed 2026-04-29 | $788.10M derived: sum of 2 quarters · filed 2026-04-29 | $990.10M derived: sum of 3 quarters · filed 2026-04-29 | $1.16B derived: sum of 4 quarters · filed 2026-04-29 |
| 2024-12-31 | $756.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $958.80M derived: sum of 2 quarters · filed 2026-02-11 | $1.13B derived: sum of 3 quarters · filed 2026-02-11 | $1.34B 10-K · filed 2026-02-11 |
| 2024-09-30 | $202.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $374.70M derived: sum of 2 quarters · filed 2025-10-29 | $585.00M 10-Q · filed 2025-10-29 | $773.10M derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-06-30 | $172.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-01 | $383.00M 10-Q · filed 2025-08-01 | $571.10M derived: sum of 3 quarters · filed 2026-02-11 | $768.70M derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-03-31 | $210.30M 10-Q · filed 2025-04-25 | $398.40M derived: sum of 2 quarters · filed 2026-02-11 | $596.00M derived: sum of 3 quarters · filed 2026-02-11 | $786.80M derived: sum of 4 quarters · filed 2026-02-11 |
| 2023-12-31 | $188.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $385.70M derived: sum of 2 quarters · filed 2026-02-11 | $576.50M derived: sum of 3 quarters · filed 2026-02-11 | $846.00M 10-K · filed 2026-02-11 |
| 2023-09-30 | $197.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-25 | $388.40M derived: sum of 2 quarters · filed 2024-10-25 | $657.90M 10-Q · filed 2024-10-25 | $821.90M derived: sum of 4 quarters · filed 2025-02-07 |
| 2023-06-30 | $190.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-26 | $460.30M 10-Q · filed 2024-07-26 | $624.30M derived: sum of 3 quarters · filed 2025-02-07 | $883.40M derived: sum of 4 quarters · filed 2025-02-07 |
| 2023-03-31 | $269.50M 10-Q · filed 2024-04-26 | $433.50M derived: sum of 2 quarters · filed 2025-02-07 | $692.60M derived: sum of 3 quarters · filed 2025-02-07 | $1.10B derived: sum of 4 quarters · filed 2025-02-07 |
| 2022-12-31 | $164.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-07 | $423.10M derived: sum of 2 quarters · filed 2025-02-07 | $835.10M derived: sum of 3 quarters · filed 2025-02-07 | $947.00M 10-K · filed 2025-02-07 |
| 2022-09-30 | $259.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-27 | $671.10M derived: sum of 2 quarters · filed 2023-10-27 | $783.00M 10-Q · filed 2023-10-27 | $993.80M derived: sum of 4 quarters · filed 2024-02-14 |
| 2022-06-30 | $412.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-28 | $523.90M 10-Q · filed 2023-07-28 | $734.70M derived: sum of 3 quarters · filed 2024-02-14 | $741.70M derived: sum of 4 quarters · filed 2024-02-14 |
| 2022-03-31 | $111.90M 10-Q · filed 2023-04-28 | $322.70M derived: sum of 2 quarters · filed 2024-02-14 | $329.70M derived: sum of 3 quarters · filed 2024-02-14 | $437.20M derived: sum of 4 quarters · filed 2024-02-14 |
| 2021-12-31 | $210.80M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14 | $217.80M derived: sum of 2 quarters · filed 2024-02-14 | $325.30M derived: sum of 3 quarters · filed 2024-02-14 | $533.90M 10-K · filed 2024-02-14 |
| 2021-09-30 | $7.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-28 | $114.50M derived: sum of 2 quarters · filed 2022-10-28 | $323.10M 10-Q · filed 2022-10-28 | $2.51B derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-06-30 | $107.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-29 | $316.10M 10-Q · filed 2022-07-29 | $2.51B derived: sum of 3 quarters · filed 2023-02-14 | $4.61B derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-03-31 | $208.60M 10-Q · filed 2022-04-29 | $2.40B derived: sum of 2 quarters · filed 2023-02-14 | $4.50B derived: sum of 3 quarters · filed 2023-02-14 | $4.51B derived: sum of 4 quarters · filed 2023-02-14 |
| 2020-12-31 | $2.19B derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-14 | $4.29B derived: sum of 2 quarters · filed 2023-02-14 | $4.30B derived: sum of 3 quarters · filed 2023-02-14 | $4.36B 10-K · filed 2023-02-14 |
| 2020-09-30 | $2.10B derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-29 | $2.11B derived: sum of 2 quarters · filed 2021-10-29 | $2.17B 10-Q · filed 2021-10-29 | $2.22B derived: sum of 4 quarters · filed 2022-02-11 |
| 2020-06-30 | $3.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-30 | $67.50M 10-Q · filed 2021-07-30 | $120.70M derived: sum of 3 quarters · filed 2022-02-11 | $124.10M derived: sum of 4 quarters · filed 2022-02-11 |
| 2020-03-31 | $63.80M 10-Q · filed 2021-04-28 | $117.00M derived: sum of 2 quarters · filed 2022-02-11 | $120.40M derived: sum of 3 quarters · filed 2022-02-11 | $1.83B derived: sum of 4 quarters · filed 2022-02-11 |
| 2019-12-31 | $53.20M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-11 | $56.60M derived: sum of 2 quarters · filed 2022-02-11 | $1.77B derived: sum of 3 quarters · filed 2022-02-11 | $1.88B 10-K · filed 2022-02-11 |
| 2019-09-30 | $3.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-27 | $1.72B derived: sum of 2 quarters · filed 2020-10-27 | $1.83B 10-Q · filed 2020-10-27 | $1.92B derived: sum of 4 quarters · filed 2021-02-16 |
| 2019-06-30 | $1.71B derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-29 | $1.82B 10-Q · filed 2020-07-29 | $1.91B derived: sum of 3 quarters · filed 2021-02-16 | $1.98B derived: sum of 4 quarters · filed 2021-02-16 |
| 2019-03-31 | $109.70M 10-Q · filed 2020-04-29 | $199.80M derived: sum of 2 quarters · filed 2021-02-16 | $266.00M derived: sum of 3 quarters · filed 2021-02-16 | |
| 2018-12-31 | $90.10M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-16 | $156.30M derived: sum of 2 quarters · filed 2021-02-16 | $185.50M 10-K · filed 2021-02-16 | |
| 2018-09-30 | $66.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $95.40M 10-Q · filed 2019-11-05 | ||
| 2018-06-30 | $29.20M 10-Q · filed 2019-08-06 | |||
| 2017-12-31 | $3.29B 10-K · filed 2020-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |